Tryp Therapeutics Revenue and Competitors

Location

$7.6M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Tryp Therapeutics's estimated annual revenue is currently $1.7M per year.(i)
  • Tryp Therapeutics's estimated revenue per employee is $131,154
  • Tryp Therapeutics's total funding is $7.6M.

Employee Data

  • Tryp Therapeutics has 13 Employees.(i)
  • Tryp Therapeutics grew their employee count by 8% last year.

Tryp Therapeutics's People

NameTitleEmail/Phone
1
Interim CEO, Tryp TherapeuticsReveal Email/Phone
2
CEO & Group Managing DirectorReveal Email/Phone
3
VP, Drug DevelopmentReveal Email/Phone
4
Senior Director Program Management and Clinical OperationsReveal Email/Phone
5
Chief Financial OfficerReveal Email/Phone
6
ChairmanReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Tryp Therapeutics?

Tryp Therapeutics is a pharmaceutical company focused on developing compounds with known activity and/or safety profiles for the treatment of rare diseases and other diseases with high unmet medical needs. Tryp's psilocybin-for-neuropsychiatric disorders, or PFNâ„¢, program is focused on the development of synthetic psilocybin as a new class of drug for the treatment of certain neuropsychiatric-based disorders.

keywords:N/A

$7.6M

Total Funding

13

Number of Employees

$1.7M

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Tryp Therapeutics News

2022-04-20 - InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP ...

InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Doses First Patient in Clinical Trial for Psilocybin-Assisted Therapy...

2022-04-20 - Fibromyalgia Pipeline Guide 2022: Drugs in Development by ...

The pipeline guide reviews pipeline therapeutics for Fibromyalgia (Central Nervous ... Tryp Therapeutics Inc; Virios Therapeutics, Inc.

2022-04-20 - TRYP THERAPEUTICS DOSES FIRST PATIENT IN PHASE II ...

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing psilocybin-related molecules, including TRP-8803, for the...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.6M13-32%N/A
#2
$2M13-46%N/A
#3
$1.4M14-30%N/A
#4
$1.2M15-25%$2M
#5
$1.2M1515%N/A